{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:32:21Z","timestamp":1767652341690},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1176\/appi.psy.49.5.438","type":"journal-article","created":{"date-parts":[[2008,9,15]],"date-time":"2008-09-15T21:02:54Z","timestamp":1221512574000},"page":"438-441","source":"Crossref","is-referenced-by-count":18,"title":["Mania: Psychiatric Manifestations of the Antiphospholipid Syndrome"],"prefix":"10.1016","volume":"49","author":[{"given":"Haniya","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryland","family":"Pao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald L.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.49.5.438_bib0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome: Report of an International Workshop","volume":"42","author":"Wilson","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1176\/appi.psy.49.5.438_bib0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08916930410001708706","article-title":"Antiphospholipid (Hughes) syndrome","volume":"37","author":"Khamashta","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1176\/appi.psy.49.5.438_bib0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1176\/appi.psy.49.5.438_bib0020","series-title":"Hematology: Basic Principles and Practice,","first-page":"2151","year":"2005"},{"key":"10.1176\/appi.psy.49.5.438_bib0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1176\/appi.psy.49.5.438_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","article-title":"Anticardiolipin and antibeta(2)-glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits","volume":"40","author":"Avcin","year":"2001","journal-title":"Rheumatology"},{"key":"10.1176\/appi.psy.49.5.438_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1191\/0961203302lu146rr","article-title":"Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations","volume":"11","author":"Avcin","year":"2002","journal-title":"Lupus"},{"key":"10.1176\/appi.psy.49.5.438_bib0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-3223(90)90467-G","article-title":"Neuroleptic-associated autoantibodies: a prevalence study","volume":"27","author":"Canoso","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1176\/appi.psy.49.5.438_bib0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.2830270408","article-title":"Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis","volume":"27","author":"Canoso","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1176\/appi.psy.49.5.438_bib0050","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archneur.1987.00520200078024","article-title":"The spectrum of neurologic disease associated with antiphospholipid antibodies","volume":"44","author":"Levine","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1176\/appi.psy.49.5.438_bib0055","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1177\/096120339800700216","article-title":"Neurological manifestations of antiphospholipid antibody syndrome","volume":"7","author":"Brey","year":"1998","journal-title":"Lupus"},{"key":"10.1176\/appi.psy.49.5.438_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u201cmultiple sclerosis:\u201d neurological features of the antiphospholipid (Hughes) syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgrad Med"},{"key":"10.1176\/appi.psy.49.5.438_bib0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/rheumatology\/keg080","article-title":"Central nervous system involvement in the antiphospholipid (Hughes) syndrome","volume":"42","author":"Sanna","year":"2003","journal-title":"Rheumatology"},{"key":"10.1176\/appi.psy.49.5.438_bib0070","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1191\/0961203303lu392oa","article-title":"Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies","volume":"12","author":"Chapman","year":"2003","journal-title":"Lupus"},{"key":"10.1176\/appi.psy.49.5.438_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v59n0105","article-title":"High association of anticardiolipin antibodies with psychosis","volume":"59","author":"Schwartz","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1176\/appi.psy.49.5.438_bib0080","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1176\/ajp.151.12.1841","article-title":"The antiphospholipid syndrome and psychosis","volume":"151","author":"Kurtz","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1176\/appi.psy.49.5.438_bib0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.62.3.300","article-title":"Fulminant encephalopathy due to the catastrophic antiphospholipid syndrome","volume":"62","author":"Chinnery","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1176\/appi.psy.49.5.438_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000006948","article-title":"Asymptomatic intracardiac thrombi and primary antiphospholipid syndrome","volume":"92","author":"Granel","year":"1999","journal-title":"Cardiology"},{"key":"10.1176\/appi.psy.49.5.438_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2169\/internalmedicine.33.373","article-title":"A young case with multi-infarct dementia associated with lupus anticoagulant","volume":"33","author":"Kurita","year":"1994","journal-title":"Intern Med"},{"key":"10.1176\/appi.psy.49.5.438_bib0100","first-page":"255","article-title":"Sneddon\u2019s disease: presenting with visual loss and dementia","author":"Wilson","year":"1988","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1176\/appi.psy.49.5.438_bib0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0447.1993.tb03349.x","article-title":"Autoimmunity in depression: increased antiphospholipid autoantibodies","volume":"83","author":"Maes","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1176\/appi.psy.49.5.438_bib0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/jnp.5.1.37","article-title":"Neurobehavioral presentations of the antiphospholipid antibody syndrome","volume":"5","author":"Gorman","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1176\/appi.psy.49.5.438_bib0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI119572","article-title":"Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies: a mouse model","volume":"100","author":"Ziporen","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1176\/appi.psy.49.5.438_bib0120","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1191\/0961203303lu500oa","article-title":"CNS dysfunction in the antiphospholipid syndrome","volume":"12","author":"Katzav","year":"2003","journal-title":"Lupus"},{"key":"10.1176\/appi.psy.49.5.438_bib0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","article-title":"Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosis","volume":"99","author":"Toubi","year":"1995","journal-title":"Am J Med"},{"key":"10.1176\/appi.psy.49.5.438_bib0130","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosis: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1176\/appi.psy.49.5.438_bib0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1191\/0961203303lu497oa","article-title":"Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus","volume":"12","author":"Denburg","year":"2003","journal-title":"Lupus"},{"key":"10.1176\/appi.psy.49.5.438_bib0140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11926-002-0083-0","article-title":"Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome)","volume":"4","author":"Cuadrado","year":"2002","journal-title":"Curr Rheumatol Reports"},{"key":"10.1176\/appi.psy.49.5.438_bib0145","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2165\/00003495-200565110-00004","article-title":"Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications","volume":"65","author":"Sperner-Unterweger","year":"2005","journal-title":"Drugs"},{"key":"10.1176\/appi.psy.49.5.438_bib0150","series-title":"Textbook of Psychosomatic Medicine","first-page":"235","year":"2005"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318208709034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318208709034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T18:22:30Z","timestamp":1545762150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318208709034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0033318208709034"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.49.5.438","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}